Dyadic International, Inc. (DYAI)
0.503
-0.01
(-2.12%)
USD |
NASDAQ |
Sep 10, 12:44
Dyadic International Enterprise Value : 19.10M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 19.10M |
| September 08, 2026 | 19.33M |
| September 04, 2026 | 19.33M |
| September 03, 2026 | 18.62M |
| September 02, 2026 | 19.48M |
| September 01, 2026 | 19.77M |
| August 31, 2026 | 20.60M |
| August 28, 2026 | 22.75M |
| August 27, 2026 | 23.66M |
| August 26, 2026 | 24.43M |
| August 25, 2026 | 25.56M |
| August 24, 2026 | 25.13M |
| August 21, 2026 | 25.52M |
| August 20, 2026 | 25.88M |
| August 19, 2026 | 27.30M |
| August 18, 2026 | 28.22M |
| August 17, 2026 | 28.81M |
| August 14, 2026 | 28.62M |
| August 13, 2026 | 28.44M |
| August 12, 2026 | 32.44M |
| August 11, 2026 | 38.64M |
| August 10, 2026 | 36.64M |
| August 07, 2026 | 36.82M |
| August 06, 2026 | 37.54M |
| August 05, 2026 | 35.70M |
| Date | Value |
|---|---|
| August 04, 2026 | 39.73M |
| August 03, 2026 | 39.00M |
| July 31, 2026 | 38.64M |
| July 30, 2026 | 39.37M |
| July 29, 2026 | 39.00M |
| July 28, 2026 | 39.00M |
| July 27, 2026 | 41.55M |
| July 24, 2026 | 43.74M |
| July 23, 2026 | 44.47M |
| July 22, 2026 | 47.75M |
| July 21, 2026 | 53.94M |
| July 20, 2026 | 44.47M |
| July 17, 2026 | 46.29M |
| July 16, 2026 | 43.74M |
| July 15, 2026 | 44.83M |
| July 14, 2026 | 44.47M |
| July 13, 2026 | 37.54M |
| July 10, 2026 | 39.00M |
| July 09, 2026 | 39.37M |
| July 08, 2026 | 36.70M |
| July 07, 2026 | 39.00M |
| July 06, 2026 | 35.63M |
| July 02, 2026 | 34.65M |
| July 01, 2026 | 37.54M |
| June 30, 2026 | 33.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 557.00M |
| Amgen, Inc. | 254.84B |
| Anika Therapeutics, Inc. | 266.28M |
| BioCryst Pharmaceuticals, Inc. | 2.731B |
| Imunon, Inc. | 8.026M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.124M |
| Revenue (Quarterly) | 0.9611M |
| Total Expenses (Quarterly) | 3.085M |
| EPS Diluted (Quarterly) | -0.0583 |
| Gross Profit Margin (Quarterly) | -2.39% |
| Profit Margin (Quarterly) | -221.0% |
| Earnings Yield | -42.27% |
| Normalized Earnings Yield | -42.27 |